References

1.      Sharma D, Farahbakhsh N, Shastri S, Sharma P. Intrauterine growth restriction – part 2. J Matern Fetal Neonatal Med. 2016 Dec 16; 29(24):4037–48.

2.      McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth Weight in Relation to Morbidity and Mortality among Newborn Infants. N Engl J Med. 1999 Apr 22; 340(16):1234–8.

3.      Lee AC, Katz J, Blencowe H, et al. National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010. The Lancet Global Health. 2013;1(1):e26-e36.

4.      Bhat MA, Kumar P, Bhansali A, Majumdar S, Narang A. Hypoglycemia in small for gestational age babies. Indian J Pediatr. 2000;67(6):423–7.

5.      Collins JE, Leonard JV, Teale D, Marks V, Williams DM, Kennedy CR, et al. Hyperinsulinaemic hypoglycaemia in small for dates babies. Arch Dis Child. 1990;65:1118-20.

6.      Hoe FM, Thornton PS, Wanner LA, Steinkrauss L, Simmons RA, Stanley CA. Clinical features and insulin regulation in infants with a syndrome of prolonged neonatal hyperinsulinism. J Pediatr. 2006;148:207-12.

7.      Hawdon JM, Weddell A, Aynsley-Green A, Ward Platt MP. Hormonal and metabolic response to hypoglycaemia in small for gestational age infants. Arch Dis Child. 1993;68:269-73.

8.      De León DD, Stanley CA. Determination of Insulin for the Diagnosis of Hyperinsulinemic Hypoglycemia. Best practice & research Clinical endocrine-ology & metabolism. 2013;27(6):763-769.

9.      Avatapalle HB, Banerjee I, Shah S, et al. Abnormal Neurodevelopmental Outcomes are Common in Children with Transient Congenital Hyperinsulinism. Frontiers in Endocrinology. 2013;4:60.

10.  Arnoux J-B, Verkarre V, Saint-Martin C, et al. Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet Journal of Rare Diseases. 2011;6:63.

11.  De Lonlay P, Fournet JC, Touati G, Groos MS, Martin D, Sevin C, et al. Heterogeneity of persistent hyperinsuli-naemic hypoglycaemia. A series of 175 cases. Eur J Pediatr. 2002;161(1):37–48.

12.  Arya VB, Flanagan SE, Kumaran A, et al. Clinical and molecular characterisation of hyperinsulinaemic hypoglycaemia in infants born small-for-gestational age. Ar-chives of Disease in Childhood Fetal and Neonatal Edition. 2013;98(4):F356-F358.

13.  Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N Engl J Med. 1996;334(4):246–54.

14.  Ben-Ari J, Greenberg M, Nemet D, Edelstein E, Eliakim A. Octreotide-induced hepatitis in a child with persistent hyperinsulinemia hypoglycemia of infa-ncy. Journal of pediatric endocrinology & metabolism: JPEM. 2013;26(1–2):179–82.

15.  Rose SR, Chrousos G, Cornblath M, Sidbury J. Management of postoperative nesidioblastosis with zinc protamine glucagon and oral starch. J Pediatr. 1986;108(1):97–100.

16.  Mohnike K, Blankenstein O, Pfuetzner A, Potzsch S, Schober E, Steiner S, et al. Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon. Horm Res. 2008;70(1):59–64.

17.  Cornblath M, Reisner SH. Blood Glucose in the Neonate and Its Clinical Significance. N Engl J Med. 1965 Aug 12;273(7):378–81.

18.  Thornton PS, Stanley CA, De Leon DD, Harris D, Haymond MW, Hussain K, et al. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypogly-cemia in Neonates, Infants, and Children. J Pediatr. 167(2):238–45.

Corresponding Author

Dr Jogender Kumar

Senior Resident, Newborn Unit, Third Floor, Nehru Hospital, Post Graduate Institute of Medical Education and Research, Chandigarh, India.160012

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.